Protein Purification And Isolation Market Worth $11.2 Billion By 2027

The global protein purification and isolation market size is expected to reach USD 11.2 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 8.3% over the forecast period. An increase in technological advancements and investments for the development of structure-based drugs by both private and public research organizations are driving the demand for protein purification and isolation products.

Rising demand for the development of single-use products for purification due to the increasing need to classify novel protein-based ligands with high specificity and improved proteomics research is further driving the market growth. Another factor driving the adoption rate of protein purification techniques is the availability of an extensive range of innovative resins for various applications.

The key players operating in the market are Merck KGaA; Thermo Fisher Scientific; Qiagen; Sigma-Aldrich Co.; GE Healthcare; Agilent Technologies; Bio-Rad Laboratories, Inc.; Norgen Biotek Corporation; Abcam plc, and Promega Corporation. Market players are adopting strategies such as the expansion of product portfolio through R&D initiatives, mergers, acquisitions, and strategic collaborations to further strengthen their position in the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/protein-purification-isolation-market

Further key findings from the report suggest:

The reagents segment is estimated to register a significant growth rate over the forecast period. This is attributed to its high usage in cell lysis and increased commercialization of advanced resins
On the basis of technology, chromatography emerged as the leading segment in 2019 owing to the availability of a varied range of products, enhanced results for complex protein purification, and high reliability
Drug screening is estimated to be the fastest-growing application segment over the forecast period owing to factors such as high efficacy and increasing R&D investments by manufacturers for the screening of novel drugs
Contract research organizations (CROs) are projected to witness a significant growth rate over the forecast period. This is attributed to increasing R&D investments and the growing number of preclinical trials outsourced by drug development firms
North America dominated the global protein purification and isolation market in 2019 owing to factors such as established research infrastructure, presence of major players, and technological advancements in the region
Asia Pacific is estimated to register the highest CAGR over the forecast period due to increasing economic stability, a growing number of CROs, and R&D activities in academic and research institutes.

Allergy Diagnostics & Therapeutics Market Worth $51.95 Billion By 2026

The global allergy diagnostics and therapeutics market size is expected to reach USD 51.95 billion by 2026 registering a CAGR of 6.3%, according to a new study by Grand View Research, Inc. Increasing prevalence of allergic conditions coupled with adoption of immunoassay as diagnostic test is expected to serve this market with lucrative growth opportunities. According to the report published by the World Allergy Journal in May 2014, around 300 million cases of asthma and 200 to 250 million cases of food allergies were reported. This number is expected to increase over the forecast period due to sedentary lifestyle and poor dietary habits.

cropped view of doctor in white coat and latex gloves holding marker pen near marked female hand

Rising industrial pollution, rapid urbanization in developing countries, and increasing Greenhouse Gas (GHG) concentrations are expected to result in increased prevalence of pollen induced respiratory disorder, thereby boosting the overall market growth over the forecast period. Emergence of technologically advanced products, such as MeDALL allergen-chip for allergy determination, is further expected to propel the market growth in the years to come.

The global market is highly competitive and is led by companies including Thermo Fisher Scientific, Omega Diagnostics, Siemens Healthcare, Stallergenes Greer, Lincoln Diagnostics, bioMerieux, HOB Biotech Group, Alcon Laboratories, Hycor Biomedical, and Hitachi Chemical Diagnostics. Most of the industry participants focus on the development of advanced products and technologies to gain competitive advantage. For instance, in March 2015, Stallergenes received approval for STG 320 in Japan, which is the first sublingual immunotherapy tablet used in the treatment of house dust mite allergy.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/allergy-diagnostic-market

Further key findings from the study suggest:

Instruments product segment is anticipated to witness the highest CAGR of 12.2% from 2019 to 2025 due to high demand for analyzers and laminators for allergy diagnostics
In vitro is expected to be the largest as well as fastest-growing test segment over the estimated period on account of rising demand for minimally invasive and allergen-specific tests
Antihistamines drug class led the allergy diagnostics and therapeutics market in 2018 due to its advantages, such as non sedating nature and minimum side effects with use of second generation antihistamines in allergy treatment
Immunotherapy vaccines is expected to register the maximum CAGR from 2019 to 2025 owing to extensive R&D in the field and advent of sublingual immunotherapy tablets in the treatment of allergic rhinitis
For instance, in April 2014, the U.S. FDA approved a five-grass pollen sublingual tablet (Ex-Oralair) by Stallergenes, which is used in the treatment of pollen allergy

Automotive Collision Repair Market Size Worth $208.0 Billion By 2025

The global automotive collision repair market size is expected to reach USD 208.0 billion by 2025, according to a new study by Grand View Research, Inc. It is projected to register a CAGR of 2.3% during the forecast period. Technological advancements and subsequent development of innovative repair techniques are anticipated to boost the market. For instance, a new production technology, 3D printing of automotive parts, is extensively being deployed by key players to optimize their production costs. This technique enable efficient fabrication performance and reduces emission toxicity.

In addition, growing adoption of alternative fuel vehicles is anticipated to propel the market in the forthcoming years. The U.S. government has implemented several initiatives to support the sales and use of alternative-fuel vehicles such as cars and trucks that run on hydrogen and natural gas. For instance, in California, air quality is an important concern on account of which, the Federal Clean Air Act by the California Air Resources board was implemented to reduce the vehicle emissions.

The market poses promising growth prospects throughout the forecast period, owing to the combination of numerous factors such as increasing investments and research undertaken by manufacturers to customize and diversify products. For instance, 3M Automotive Aftermarket Division and West Coast Customs, a car customization company, entered into a partnership to use 3M refinishing products such as abrasives, body fillers, adhesives, coatings, paint finishing, and spray paint guns for primer. This enabled manufacturers to enter the car customization segment.

Introduction of new generation of vehicles in the novel service repair regimes is boosting the demand for gas and hybrid electric cars, which is expected to further drive the overall market. Furthermore, unorganized and untapped markets in Asia Pacific are anticipated to create growth opportunities for major vehicle repair vendors, which is expected to propel the global automotive collision repair market in the forthcoming years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/automotive-collision-repair-market

Further key findings from the report suggest:

Incorporation of advanced telematics such as automotive or vehicle telematics act as a challenge to market growth. In the automotive industry, telematics permits manufacturers to use in-vehicle equipment such as navigation devices, communication systems, GPS, and event data recorders and offer a wide range of information and services
Europe held the largest share of over 44.0% in the global automotive collision repair market in 2018. Penetration of vehicles with enhanced safety features will drive the regional market
Regulations for alternative fuel vehicles were implemented to reduce the current tax rate for advanced technology vehicles. Government agencies have implemented rules for passenger cars, which is expected to positively impact component sales
Key market players include 3M; Automotive Technology Products LLC; Continental AG; Denso Corporation; Faurecia; Federal-Mogul LLC; Honeywell International, Inc.; International Automotive Components Group; Johnson Controls, Inc.; Magna International, Inc.; Mann+Hummel Group; Martinrea International, Inc.; Mitsuba Corporation; Robert Bosch GmbH; and Takata Corporation.

Cell Expansion Market Worth $39.7 Billion By 2027

The global cell expansion market size is expected to reach USD 39.7 billion by 2027 registering a CAGR of 9.4%, according to a new report by Grand View Research, Inc. Cell expansion techniques are increasingly employed for the development of cellular and gene therapies from a single cord blood collection. These techniques can also be used for the expansion of stored Stem Cells (SCs) for the development of cancer therapies. Therefore, significant developments in cord blood SCs expansion technologies are expected to boost market growth.

Companies have made heavy investments for the expansion of tissue-engineered products and the development of biologics. For instance, in March 2019, Merck KGaA invested USD 168 million for the expansion of its biologics manufacturing facility in Switzerland. Such initiatives are expected to boost the demand for solutions required for biologic development, thereby leading to market growth.

Bioreactors are fundamental tools in this market. Extensive research studies related to the applications of bioreactor engineering approaches have led to the incorporation of novel culture technologies. Moreover, the combined use of automated bioreactors with the microcarrier technology leads to an efficient expansion and enrichment of the cancer SCs. As a result, these approaches have gained immense traction in this market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/cell-expansion-market

Further key findings from the report suggest:

Broad portfolio of automated expansion systems along with improvements in bioreactor design for large-scale bioproduction results in the lucrative growth opportunity for instruments
The microbial cells segment is expected to witness the fastest growth rate owing to the implementation of high-throughput cultivation approaches and techniques that avoid the formation of biofilms
Biopharmaceuticals segment held the largest revenue share in 2019 due to growth in the demand for biosimilars, continuous R&D investments in biomanufacturing, and rise in the number of approvals for biologics
Asia Pacific is anticipated to grow at the maximum CAGR from 2020 to 2027 due to presence of several consortiums that focus on the evolving fields in the biomedical industry
For instance, in November 2019, the Cell & Gene Therapy Asia 2019 held in Japan focused on the evolving field of SCs for their deployment in pharmaceutical discovery and cellular therapies

Ultrasound Probe Disinfection Market Size Worth $700.3 Million By 2027

The global ultrasound probe disinfection market size is expected to reach USD 700.3 million by 2027 registering a CAGR of 9.4%, according to a new report by Grand View Research, Inc. Increasing number of ultrasound imaging procedures, rising prevalence of nosocomial infections, and technological advancements are the key driving factors for the global market.

Nosocomial or Hospital-acquired Infection (HAI) is an infection acquired in healthcare facilities, such as hospitals, clinics, rehabilitation facilities, and Ambulatory Surgery Centers (ASCs). Factors, such as use of indwelling catheters, lack of proper hygiene in the healthcare setting, and excessive use of antibiotics, can increase the risk of HAIs in patients. Thus, it is very crucial to disinfect all the devices used in healthcare settings.

The increasing number of ultrasound imaging procedures across the globe is anticipated to increase the product demand over the forecast period. According to the report published by the U.S. Department of Health & Human Services, on any given day, approximately one in 31 patients suffers from at least one HAI. Similarly, the WHO reported that out of every 100 patients on any given day, ten in developing countries and seven in developed countries acquire at least one HAI. Ultrasound probe disinfection eliminates the risk of transmission of any pathogen from one patient to another, which is anticipated to boost the demand over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/ultrasound-probe-disinfection-market

Further key findings from the report suggest:

In terms of revenue, consumables are anticipated to witness the fastest growth over the forecast period as these are usually disposable and need to be bought frequently
Intermediate and low-level disinfection held the largest market share in 2019 and is anticipated to witness a significant growth rate over the forecast period
Hospitals and clinics end-use segment held the largest market share in 2019 owing to the rising number of ultrasound imaging procedures performed in these healthcare facilities
Asia Pacific is expected to be the fastest-growing regional market over the forecast period owing to the increasing usage of diagnostic imaging

Non-Invasive Brain Trauma Monitoring Devices Market Worth $15.1 Billion By 2024

The global non-invasive brain trauma monitoring devices market is expected to reach USD 15.12 billion by 2024, according to a new report by Grand View Research, Inc. The rising burden of Traumatic Brain Injuries (TBI) is a leading cause of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. As a result, there are numerous initiatives taken at the regional and global levels to create awareness, which facilitated a heavy diagnosis rate, thus governing the growth of non-invasive brain trauma monitoring devices.

Technological advancements in this field are connected with accuracy, portability, and affordability, which are supporting the industry growth. For instance, recently available non-invasive intracranial pressure monitors, such as Transcranial Doppler (TCD), are accurate in positioning and creating a better pressure gradient and also bringing in more accuracy in the treatment.

The Minimally Invasive Surgeries (MIS) are less traumatic to patients and facilitate faster recovery with minimum complications. In minimally invasive neurological surgeries, non-invasive brain trauma monitoring devices play a critical role. Thus, the increasing volume of MIS is driving the industry’s growth.

The key target population in this industry includes people above 60 years. This section of the population is at a greater risk for TBIs and their co-morbidities. The global geriatric population is on arise and is a vital driver for this industry.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/non-invasive-brain-trauma-monitoring-devices-market

Further key findings from the study suggest:

Monitoring devices that include intracranial pressure monitors, MRI scanners, CT scanners, PET scanners, EEG, and MEG held a substantial share of around 60.0% in 2015. The high costs associated with this equipment and the increasing usage of these devices governed the growth of this segment.
The consumables sub-segment in the product segment is anticipated to witness lucrative growth over the forecast period. The repeat purchase of consumables and regular maintenance activities are expected to spur the demand for these products.
The market on the basis of end-use is segmented into hospitals, neurological centers, and other settings. The hospital segment dominated the end-use segment with over 75.0% of the revenue. The greater volume of surgeries performed in hospitals contributed to its growth.
On the contrary, neurological centers are expected to grow at a sturdy rate over the forecast period. The availability of specialized staff and advanced methodologies are likely to boost the demand for this segment.
North America dominated the non-invasive brain trauma monitoring devices market in 2015. The advanced healthcare system, high awareness level, and well-planned reimbursement policies helped this market to grow in this region. However, Asia Pacific is anticipated to witness significant growth over the forecast period.
Some key players operating in this industry include Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Advanced Brain Monitoring, CAS Medical Systems, Inc., Siemens, Compumedics Ltd., Medtronic Plc., and Integra LifeSciences. New product launches, co-developments, and acquisitions are the key initiatives in this industry.
For instance, in January 2013, Natus Medical acquired Astro-Med’s products included in monitoring and neurodiagnostic products. This acquisition helped the company to widen the portfolio of EEG systems.

qPCR & dPCR Market Size Worth $4.33 Billion By 2026

The global real-time pcr and digital pcr market size is anticipated to reach USD 4.33 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 8.5% during the forecast period. Growing demand for Rapid Diagnostics Tests (RTDs) is one of the high impact rendering drivers for this market. The demand for RDTs is likely to witness strong growth as local governments across the globe seek to incorporate these tests to improve the diagnosis and treatment of infectious diseases.

The emergence of RDTs as an important tool in the management of infectious diseases owing to the ability to provide rapid results in remote areas with limited healthcare infrastructure is likely to fuel the growth of the Polymerase Chain Reaction (PCR) systems which are used extensively to conduct these diagnostic procedures.

In addition, high prevalence of infectious diseases is one of the major factors contributing to the market growth. According to the estimates by the World Health Organization (WHO), lower respiratory infections, diarrheal diseases, and tuberculosis were ranked among the top ten causes of deaths worldwide in 2016. New cases of other infectious diseases, such as HIV/AIDS and malaria among others continue to witness sharp increase in developing countries which is expected to substantially increase the patient population, driving the need for better diagnosis options.

Furthermore, inorganic growth strategies such as mergers and acquisitions employed by major PCR manufacturers to broaden their product portfolio and to develop novel qPCR and dPCR products is another factor expected to propel the market during the forecast period. For instance, in January 2017, RainDance Technologies, Inc. was acquired by Bio-Rad Laboratories, Inc. which is expected to strengthen the company’s position in the field of droplet digital PCR and next generation sequencing.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/real-time-pcr-qpcr-digital-pcr-dpcr-market

Further key findings from the study suggest:

qPCR held the largest market share in 2018 due to the accuracy and wide applications of the technology in quantification of gene expression, pathogen detection and microRNA analysis
Digital PCR is estimated to be the fastest growing segment due to precise quantification of target sequences
Consumables and reagents led the product segment and is likely register the fastest CAGR of 8.9% over the forecast period due strong uptake in the use of PCR kits in diagnostic tests
Research application was the largest segment in terms of value in 2018, due to wide-spread use in research areas, such as stem cells, microbiology, and agriculture
Clinical application is expected to witness robust growth over the forecast period due to the adoption of automated processes
North America held the largest market share in terms of revenue in 2018 due launch of new PCR products along with rising demand for rapid diagnostic tests
Asia Pacific is projected to register comparatively strong growth during the forecast period owing to burgeoning patient population as a result of prevalence of infectious diseases
Prominent players in the qPCR and dPCR market include Bio-Rad Laboratories; Thermo Fisher Scientific Inc.; Qiagen N.V.; Abbott Laboratories, Inc.; and others

Blood Culture Test Market Worth $7.3 Billion by 2026

The global blood culture test market size is expected to reach USD 7.3 billion, at a CAGR of 9.1% by 2026, according to a new report by Grand View Research, Inc. Increasing prevalence of bloodstream infections and infectious diseases is the most significant factor anticipated to propel the growth. Rising demand for advanced diagnostic techniques for the diagnosis of infectious diseases, such as sepsis, is projected to drive the growth. Thus, many manufacturing companies have begun focusing on development of advanced diagnostic instruments and consumables. For instance, Cepheid offers Xpert MRSA/SA assay that aids in accurate detection of SA and MRSA in positive blood culture specimens in about an hour.

Introduction of various government initiatives pertaining to the prevention and control of infections is likely to propel the demand for blood culture tests. According to the Centers for Disease Control and Prevention (CDC), there was 46% decrease in central line-associated bloodstream infections in U.S. between 2008 and 2013, owing to the efforts taken by the U.S. government for the prevention of Hospital-acquired Infections (HAIs).

Click the link below:
https://www.grandviewresearch.com/industry-analysis/blood-culture-tests-market

Further key findings from the report suggest:

Conventional blood culture technique was the largest revenue-grossing segment in 2018 owing to increased applications of this method in hospitals, independent clinical laboratories, and pathology laboratories
In product segment, consumables accounted for the largest market share in terms of revenue in 2018, due the product applications in diagnostics and research, with repetitive purchase, such as blood culture media, assay, kits, and reagents, adding to the revenue
Automated blood culture systems is the fastest growing segment owing to the advantages of automation, such as low chances of error and faster result generation
Molecular technology is projected to expand at the highest CAGR over the forecast period, due to rising demand for advanced products by hospitals and laboratories for diagnosis of infectious diseases
Bacterial infections accounted for the largest revenue share in 2018, due to the fact that they are the most common cause for infection in the blood
Reference laboratories is projected to expand at the highest CAGR during the study period, because there is an increase in outsourcing of blood tests by hospitals to reference laboratories
North America accounted for the largest revenue share of the blood culture test market in 2018, due to the presence of well-developed healthcare infrastructure in this region
Asia Pacific is anticipated to register the highest CAGR during the forecast period owing to increased focus of government on the prevention of infectious diseases
Few key players include Becton, Dickinson and Company; bioMérieux SA; Thermo Fisher Scientific, Inc.; Danaher Corporation; Luminex Corporation; Roche; Bruker Corporation; and Abbott Laboratories.

Allergy Diagnostics & Therapeutics Market Worth $51.95 Billion By 2026

Click the link below:
https://www.grandviewresearch.com/industry-analysis/allergy-diagnostic-market

Further key findings from the study suggest:

Instruments product segment is anticipated to witness the highest CAGR of 12.2% from 2019 to 2025 due to high demand for analyzers and laminators for allergy diagnostics
In vitro is expected to be the largest as well as fastest-growing test segment over the estimated period on account of rising demand for minimally invasive and allergen-specific tests
Antihistamines drug class led the allergy diagnostics and therapeutics market in 2018 due to its advantages, such as non sedating nature and minimum side effects with use of second generation antihistamines in allergy treatment
Immunotherapy vaccines is expected to register the maximum CAGR from 2019 to 2025 owing to extensive R&D in the field and advent of sublingual immunotherapy tablets in the treatment of allergic rhinitis
For instance, in April 2014, the U.S. FDA approved a five-grass pollen sublingual tablet (Ex-Oralair) by Stallergenes, which is used in the treatment of pollen allergy

Contrast Media Injectors Market Size Worth $1.4 Billion By 2025

The global contrast media injectors market size is expected to reach USD 1.4 billion by 2025, growing at a CAGR of 5.8%, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive surgical procedures is a major factor expected to boost the market during the forecast period. These devices assist surgeons in accurate insertion of contrast agents with reduced human errors, thus increasing the accuracy and efficiency of surgical procedures. They play a crucial role in Intraoperative Computed Tomography (iCT), Intraoperative Magnetic Resonance Imaging (iMRI), and interventional cardiology. Availability of advanced injector systems for diagnosis and intraoperative imaging has boosted adoption of these systems. For instance, Medrad Stellant CT injection system integrated with Certegra Workstation provides high efficiency and accuracy in CT imaging.

Technological advancements, such as automated contrast media injectors and double-head injectors, are also among major factors supporting the growth of the market. Automated contrast media injectors provide improved patient safety, accuracy, and enhance image quality. Also, double-head injectors allow a large and rapid initial bolus of contrast, which is required in several imaging procedures. For instance, in cardiac CT, a fast injection is required for imaging of both sides of the ventricular septum to identify septal thickness, shunts, and enlarged ventricles. Delivery of contrast media is more efficient and controlled with a dual-head injector.

To request a sample copy, click the link below:
http://www.grandviewresearch.com/industry-analysis/contrast-media-injectors

Further Key Findings From the Report Suggest:

CT injector systems segment was the largest revenue-generating segment of the market in 2016 owing to availability of technologically advanced products and their widespread application for disease diagnosis and image-guided surgeries
The single head injectors segment accounted for the largest revenue share in 2016 and is expected to maintain its dominance throughout the study period
In the application segment, interventional cardiology is projected grow at the highest rate during the forecast period because of rising prevalence of cardiac diseases, such as coronary artery disease, heart valve disease, and peripheral vascular disease
In 2016, hospitals dominated the market in terms of revenue because of an increase in the number of hospital admissions of patients suffering from cancer, neurological disorders, and cardiovascular diseases
The North America contrast media injectors market held the largest revenue share in 2016 and is projected to maintain its dominance during the forecast period owing to well-established healthcare infrastructure
Some of the major players are Bayer HealthCare LLC; Guerbet Group; Bracco Group; Medtron AG; GE Healthcare; Nemoto Kyorindo Co., Ltd.; Ulrich GmbH & Co. KG; VIVID IMAGING; Sino Medical-Device Technology Co., Ltd.; and APOLLO RT Co. Ltd.

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com